KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts
NCT06469450 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2024-06-21
Summary
A majority of high-risk patients does not achieve their cholesterol target levels and most of these patients do not receive more effective combination therapy, which goes beyond statin monotherapy. Large interindividual differences in treatment outcomes have been observed for patients receiving statins. Statins block cholesterol synthesis and increase cellular low-density lipoprotein (LDL) uptake. Importantly, LDL uptake is highly divergent in individuals.The aim of this trial is to investigate how atorvastatin influences leukocyte readouts of LDL uptake and lipid storage in humans. The trial is a single-arm, open-label, interventional trial. A total of 15 healthy volunteers will receive 40 mg atorvastatin once a day for 4 weeks. The participants will provide blood samples before starting the atorvastatin intervention, each week when taking atorvastatin, and one week after the end of the intervention for the measurement of leukocyte readouts of LDL uptake and lipid storage.
Conditions
- Pharmacodynamics
Interventions
- DRUG
-
one 40 mg atorvastatin tablet once daily for 28 days
Sponsors & Collaborators
-
University of Helsinki
collaborator OTHER -
Mikko Niemi
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-20
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Finland
Study Locations
More Related Trials
-
CKD-337(2) Drug-drug Interaction Study
NCT02422030 ·Status: COMPLETED ·Phase: PHASE1
-
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
NCT00120055 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.
NCT02994745 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
NCT02099123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
NCT06699355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
NCT02659397 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
NCT00361283 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects
NCT02093390 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers
NCT02397590 ·Status: COMPLETED ·Phase: PHASE1
-
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
NCT00442845 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
NCT00990808 ·Status: COMPLETED ·Phase: PHASE1
-
Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
NCT00150371 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
NCT03482180 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
NCT03438955 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
NCT00141232 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Ascending Dose and DDI Study
NCT03031119 ·Status: COMPLETED ·Phase: PHASE1
-
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
NCT00195793 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Effects of Statins and Exercise on Training Sensitive Health Markers
NCT06841536 ·Status: COMPLETED ·Phase: NA
-
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma
NCT06157099 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pharmacological Regulation of Fat Transport in Metabolic Syndrome
NCT00632840 ·Status: COMPLETED ·Phase: PHASE4
-
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
NCT00669695 ·Status: TERMINATED ·Phase: PHASE2
-
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
NCT03611010 ·Status: COMPLETED ·Phase: PHASE2
-
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet
NCT02566187 ·Status: COMPLETED ·Phase: PHASE1
-
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
NCT00664859 ·Status: COMPLETED ·Phase: PHASE2/PHASE3